Brief: CareRx Corp Receives Regulatory Approval For Launch Of Its Normal Course Issuer Bid
Sept 5 (Reuters) - CareRx Corp CRRX.TO :
* CARERX CORP - CARERX CORPORATION RECEIVES REGULATORY
APPROVAL
FOR LAUNCH OF ITS NORMAL COURSE ISSUER BID
* CARERX CORP - EXPECTED THAT NORMAL COURSE ISSUER BID WILL
BEGIN
ON SEPTEMBER 7, 2023 AND WILL END ON SEPTEMBER 6, 2024
Source text for Eikon: ID:nCNWmFWHKa
Further company coverage: CRRX.TO
((Reuters.briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates
Brief: CareRx Reports Results For The Third Quarter Of 2024